naltrexone

Opinion is sharply divided on the ethics and effectiveness of pressuring opioid-dependent offenders to take the opiate-blocker naltrexone. Especially sharp is the controversy over long-acting products not approved for medical use in the UK...

Key studies on treatment’s contribution to safeguarding the community and preventing crime. Commentary addresses two highly controversial issues: whether it is ever safe to leave children with seriously problematic drug users, and the...

Time to consolidate the lessons of the online course on drug treatment's last five instalments, all on medical treatment of drug dependence. Medications most clearly mark an intervention as ‘medical’, but are never all there is to treatment...

In 1960s Britain a chasm of opposing agendas and social distance opened up between doctors treating drug addiction and their patients. This cell of the Drug Treatment Matrix examines how bridging such chasms makes treatment more effective...

In 2013 nalmefene was authorised for moderating drinking among patients not in need of detoxification, extending pharmacotherapy to less dependent drinkers. Though uniquely authorised for this purpose, this review found other (and probably...

Key Points Question: Are monthly intramuscular injections with extended-release naltrexone hydrochloride as effective as daily oral buprenorphine–naloxone hydrochloride in reducing the use of heroin and other illicit substances in newly...

The Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT) experts have recently created a virtual step-by-step XR-Naltrexone User Guide to assist you in your practice in treating opioid use disorder (OUD). XR...